Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylase kinase catalytic subunit gamma 1 pseudogene 4 (PHKG1P4) is a nonfunctional segment of human DNA located in the genome due to duplication or retrotransposition of the functional PHKG1 gene. PHKG1P4 is classified as a pseudogene, meaning it closely resembles a protein-coding gene but contains mutations—such as premature stop codons or frameshifts—that prevent the production of a functional protein product. Pseudogenes like PHKG1P4 may sometimes impact gene regulation or mRNA stability in related genes, though no specific biological function, disease link, or drug interaction is established for PHKG1P4 itself[4][2][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylase kinase catalytic subunit gamma 1 pseudogene 4 (PHKG1P4).